Skip to content

Virtual rehabilitation in patients with Parkinson's disease

Telerrehabilitation in individuals with Parkinson's disease: Single-blind randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-6h5knrj
Enrollment
Unknown
Registered
2023-03-24
Start date
2023-06-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gait

Interventions

The randomization sequence will be generated by computer, through the randomization.com randomization program, considering two groups and 2 randomized blocks of 4 participants each, by an external res
H02.010.625

Sponsors

Universidade Federal do Rio Grande do Norte
Lead Sponsor
Neurobots Pesquisa e Desenvolvimento LTDA
Collaborator

Eligibility

Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Individuals participating in a university extension project (AGruPar - Group therapy assistance for individuals with Parkinson's disease) will be recruited for the study, considering as eligibility criteria: Having clinical diagnosis of Parkinson's disease; Be between 20 and 70 years old; Being on regular drug treatment for PD; Being in the Parkinson's disease stage classified from 1 to 3 on the Modified Hoehn and Yahr Scale (HOEHN, YAHR, 1967), considered with mild to moderate disability (SHENKMAN et. al, 2001); Manage to walk for at least 10 meters without personal assistance

Exclusion criteria

Exclusion criteria: Individuals who are unable to handle the devices (computer or mobile) during remote treatment and/or who do not have a caregiver available for the appropriate purposes will be excluded; For this, before we start the evaluations will be asked if there is experience and familiarity with the management of the devices, or if there is any support for this

Design outcomes

Primary

MeasureTime frame
The primary outcome of the present study will be motor function, measured from the Movement Disorders Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) (GOETZ et. al, 2016), in part III. Part III of the scale has 18 items, and refers to a thorough motor evaluation with specific aspects, among them: stiffness, bradykinesia, tremor at rest, kinetic tremor and postural balance.

Secondary

MeasureTime frame
Gait will be evaluated by the Functional Gait Assessment (FGA) instrument, which has shown valid and reliable in the evaluation of this outcome in PD. Gait will be evaluated by the Functional Gait Assessment (FGA) instrument, which has shown valid and reliable in the evaluation of this outcome in PD.;The criteria for quality of life will be evaluated from the Parkinson Disease Questionnaire-39 (PDQ-39). This instrument is specific to measure the perception of quality of life in individuals with PD, containing 39 questions that are divided into eight domains: mobility, activities of daily living, emotional well-being, stigma, social support, cognition, communication and body discomfort.;To perform cognitive assessment, the Montreal Cognitive Assessment (MoCA) scale, validated and adapted for the Brazilian population, with good psychometric properties, will be considered an important instrument for early detection of cognitive decline.;The Timed Up and Go test (TUG), is simple and reliable, being one of the most used instruments for assessing mobility and balance in the national and international spheres. Independent adults without balance changes perform the test within 10 seconds; in individuals who are more dependent on basic transfers, the test is performed within 20 seconds, and for those individuals who are more dependent, it takes more than 20 seconds to complete the test.

Countries

Brazil

Contacts

Public ContactRaíssa Taveira

Universidade Federal do Rio Grande do Norte

raissa.taveira.rt@gmail.com+55-083-988504148

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 2, 2026